CRISPR-based gene editing therapy approved by the FDA for the first time
In a landmark decision, the FDA greenlit two new drugs for the treatment of sickle cell disease in patients 12 Leer mas
Via:: Engadget
Recent Posts
In a landmark decision, the FDA greenlit two new drugs for the treatment of sickle cell disease in patients 12 Leer mas
Via:: Engadget
En este momento no estamos por acá. Si queres envianos un correo y te contestaremos a la brevedad.